BC Environmental and Occupational Health Research Network

AICR awards project grants of between one and three years to support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. We will consider proposals in which a mixture of basic and clinical research is proposed. However, completely clinical applications, such as intervention studies, clinical trials or health care delivery research and many substantially clinical applications are beyond the remit of AICR.

JDRF provides “seed” funding for highly innovative research with potential significant impact on accelerating the mission of JDRF. The innovative research should have the potential for a change in the current paradigm or conventional wisdom or to lead to a seminal discovery or to be groundbreaking. Preliminary data is not required in the proposal but the underlying premise, goal, or hypothesis must be plausible and the proposal must be focused with a well defined goal.

JDRF fosters the development and productivity of the best and the brightest established independent researchers who will bridge the gap between the bench and bedside. The primary purpose of the Career Development Award is to attract qualified and promising scientists early in their faculty careers and to give them the opportunity to establish themselves in areas that reflect the JDRF research emphasis areas. In the five-year term of the award, awardees will focus their research efforts on a subject directly related to JDRF mission goals and research priorities, and position themselves to work at the leading edge of type 1 diabetes research. These awards are designed to assist exceptionally promising investigators. Although JDRF is especially interested in fostering careers in clinical investigation,
Career Development Awards may emphasize either basic or clinical topics.

The purpose of the Regular Research Grant mechanism is to provide investigators with support to explore the feasibility and development of proposals that are considered to be on the leading edge of diabetes research and that address the JDRF research emphasis areas. Proposals that have the potential to impact the current state of diabetes research or that clearly lead to avenues of therapeutic benefit are major considerations for the Regular Research Grant. Also of merit are exploratory proposals that may or may not have sufficient preliminary data but have a sound research development plan that is considered to be of high priority to JDRF. The Regular Research grant mechanism is specifically intended to support innovative proposals that can be developed to a level of maturity where generated data strengthens future research project grant applications for ongoing support.

CCDR grants seek to foster independent careers in research exploring the basis for differences in breast cancer outcomes and the translation of this research into clinical and public health practice interventions, particularly among junior scientists from populations affected by breast cancer disparities. Disparities research of particular interest in this funding year must be in one of these focus areas: the study of biologic determinants of disparities in breast cancer outcomes; models of clinical care that address the causes of disparities in care and outcomes across population groups; and public health interventions that specifically address the provision of health care services in community settings and associated factors contributing to disparities in breast cancer care and outcomes. All proposed research must have significant potential to lead to reductions in disparities in breast cancer incidence and/or mortality.

Career Catalyst Research (CCR) grants seek to provide unique opportunities for scientists in the early stages of their career to further their research independence by providing support for research exploring important issues and novel approaches that will lead to substantial progress in breast cancer research and reductions in breast cancer incidence and/or mortality within the next decade.

IIR Grants seek to stimulate exploration of important issues and novel approaches that will lead to reductions in breast cancer incidence and/or mortality within the next decade. All proposed research must have significant potential to lead to reductions in breast cancer incidence and/or mortality within the next decade. Research of interest in this funding year must be in one of these focus areas: breast cancer biology; genetics; molecular/genetic epidemiology; prevention; detection; risk assessment; biomarkers of risk, disease burden, and/or treatment response or resistance; novel therapeutics; lifestyle interventions with the potential to affect disease outcomes (e.g., incidence and/or mortality); and novel approaches that enhance understanding of the breast cancer disease process.

These annual grants totalling € 100,000 from Grünenthal GmbH are aimed at supporting young scientists in carrying out innovative and exploratory clinical pain research projects in any country with an EFIC chapter (see www.EFIC.org). Research Grants are intended for clinical and human experimental research projects on the subject of pain. Research proposals on animals, computer simulations etc. will not be considered. Research grants are valued at up to € 25,000 per project. The duration of projects should not be longer than two years.

AICR awards project grants of between one and three years to support fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. We will consider proposals in which a mixture of basic and clinical research is proposed. However, completely clinical applications, such as intervention studies, clinical trials or health care delivery research and many substantially clinical applications are beyond the remit of AICR. Before submitting applications of a clinical or semi-clinical nature, potential applicants are strongly encouraged to seek our advice by e-mailing a brief description of the proposed project to our Scientific Co-ordinator.

To promote individual guest placements, the Swiss National Science Foundation (SNSF) finances a limited number of short visits. Applications which:
a) relate to the funding of short visits by Swiss researchers to foreign research institutes or of short visits by foreign researchers to Swiss research institutes, and
b) are not covered by an existing agreement between the SNSF and a partner organization may be submitted to the SNSF if the following formal criteria are met: the application must be made by the researcher based at a Swiss university who is planning a short visit to a foreign research institute or by the head of the Swiss research institute which is wishing to receive a foreign visiting researcher; applicant  of the funding must have a doctorate; the visit must be intended to result in ongoing research co-operation; the minimum duration of the visit must be such that the desired objective can be achieved (at least seven days), the maximum duration may not exceed three months; the visit must not be solely in the interest of the host laboratory.

Deadline: any time, at least two months before the planned begin of research project.

The Human Frontier Science Program supports international preferably intercontinental collaborations in basic life science research with emphasis placed on novel, innovative and interdisciplinary approaches to fundamental investigations. Applications are invited for grants to support new approaches to understanding complex mechanisms of living organisms. Preliminary results are not required. Applicants are expected to develop new lines of research distinct of their ongoing research.

Grant Purpose: To support the education of women from developing countries who are committed to improving the lives of women and children in a developing country.
Previous grant recipients studied agriculture, architecture and urban planning, civil engineering, education, forestry, journalism, law, nursing, nutrition, pediatrics, public administration, public health, social sciences and social work.
For students from developing countries who are currently studying in the United States or Canada, the MMMF awards annually grants of approximately $12,000 each; grants are not renewable.

Research grants are provided for teams of scientists from different countries who wish to combine their expertise to approach questions that could not be answered by individual laboratories.
Emphasis is placed on novel collaborations that bring together scientist from different disciplines (e.g. from chemistry, physics, computer science, engineering) to focus on problems in the life sciences.
The research teams must be international. The principal applicant must be from one of the eligible countries (Canada included). However, other participating scientists and laboratories may be situated anywhere in the world.

Established in 1986 to complement our postdoctoral fellowship program, the Investigator Award Program supports accomplished assistant professors undertaking their first independent investigations in cancer immunology or general immunology. A four-year grant, the award provides flexibility and a degree of stability during this very challenging period.
Candidates for the investigator award must hold a doctoral degree and be a tenure-track Assistant Professor at the time of award activation. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad. Please note, however, that CRI does not support research at for-profit institutions.

In 1998, the Institute established the Predoctoral Emphasis Pathway in Tumor Immunology to complement its Postdoctoral Fellowship and Investigator Award Programs.
The aim of the Predoctoral Program is to attract an even younger generation of budding talent to the field of cancer immunology. It is primarily intended to introduce graduate students to basic research principles in the field of tumor immunology, excite them about research possibilities, and set them on the path to a lifelong career in the field.
Students are given the opportunity to interact with respected tumor immunologists, from among whom they will choose mentors for their doctoral research and learn about the advances and trends in cancer immunology.
The program provides $450,000 over four-year period. The payment schedule is structured to allow admission of four students in year one and an additional two students in year two. Universities must reapply for renewal in the third year to maintain the program at six students annually.

Earthwatch Institute is an international non-profit organization that supports scholarly field research worldwide in the biological, physical, social, and cultural sciences. Earthwatch supports doctoral and post-doctoral researchers, or researchers with equivalent scholarship or commensurate life experience. The Research Program welcomes proposals from advanced scholars and professionals of any nationality. In general Earthwatch considers work in any geographic region. However, geopolitical climate and other safety concerns, evaluated on a yearly basis, may cause Earthwatch not to consider funding proposals for work in some geographical areas. Scientists are advised to inquire with our office prior to submitting if there is any doubt. Applicants intending to conduct research in foreign countries are strongly encouraged to include host country nationals as part of their research staff.

AICR awards grants to support fundamental or translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. We do not support clinical research. We will consider applications that include some clinical research in a project which is mostly basic or translational. However, completely clinical applications, such as intervention studies, clinical trials or health care delivery research are beyond the remit of AICR. Before submitting applications that include clinical research, potential applicants are strongly encouraged to contact AICR for advice. We accept applications from non-profit research institutions anywhere in the world. Projects are for a maximum of three years and can include funding for research staff (post doctoral and/or PhD students), consumables, essential items of equipment and travel.

The Science and Technology Office (Scientific Service) is in charge of collaborations between French and Canadian higher education institutions in all domains of human knowledge, from the hard sciences to the humanities. The Scientific Service promotes partnerships based on the two core missions of higher education institutions: academic training and research. The spread of the knowledge-based economy and the respective interests of our societies place the Master’s and PhD levels at the top of priorities. Privileged disciplines are the in the hard sciences, engineering, economics, management, law and political science. Special attention is given to human sciences inasmuch as they allow to better ponder scientific development and to apprehend its societal significance. All conventions must include research components. The Scientific Service promotes partnerships to serve the best students, both in France and in Canada. At a time when universities are defining strategies and targeting specific partners in the context of their international agendas, the Scientific Service is at their disposal to facilitate structured collaborations in academic training and research and to make sure the most suited cooperation instruments are used. Such collaboration will pave the way for genuine lasting international partnerships.

The Man and the Biosphere Programme (MAB), proposes an interdisciplinary research agenda and capacity building aiming to improve the relationship of people with their environment globally. Launched in the early 1970s, it notably targets the ecological, social and economic dimensions of biodiversity loss and the reduction of this loss. It uses its World Network of Biosphere Reserves as vehicles for knowledge-sharing, research and monitoring, education and training, and participatory decision-making.
The MAB Young Scientists Awards targets young researchers carrying-out interdisciplinary research in line with UNESCO’s Man and the Biosphere (MAB) Programme. Priority is given to projects carried-out in biosphere reserves, on the theme of ecosystems and water. Objectives:
• to assist exchange of information and experience among a new generation of scientists.
• to encourage young scientists, in particular those from developing countries, to use UNESCO Man and the Biosphere research, project sites and biosphere reserves in their research.
• to encourage young scientists to undertake comparative studies with other sites, in or outside their country.

GSK is committed to promoting Canadian scientific discovery and innovation. Our mandate is to improve the quality of human life by enabling people to do more, feel better, and live longer. As such, GSK is proud to support medical research in Canada. The GSK CIRF-FRIC initiative is a program that aims to support Investigator Initiated research. To begin the application process interested parties must submit a letter of intent. After reviewing the letters of intent, the GSK CIRF-FRIC review committee will invite selected applicants to submit a full proposal for further evaluation. We welcome your interest in GSK’s exciting research initiative.